molecules molecules molecules molecules

Category: Our Science

Our Science|May 23, 2024

Addressing Adenosine: Immunotherapy in the Tumor Microenvironment

Targeting the adenosine axis – components that contribute to the production of adenosine and its subsequent impact – is a promising option.

Juan Jaen, Ph.D.|President at Arcus Biosciences
Dimitry S.A. Nuyten, M.D., Ph.D.   |   Chief Medical Officer at Arcus Biosciences
Read More
Our Science|January 10, 2024

The Fc-silent Treatment: Pursuing a Known Target in a New Way

We were among the first to take a different approach and pursue an Fc-silent anti-TIGIT antibody based on our own scientific understanding of how this biological pathway works.

Juan Jaen, Ph.D.|President at Arcus Biosciences
Read More
Our Science|August 15, 2023

Investigating Combination Therapies to Treat Cancer

Learn how cancer biology is guiding the study of potential, new combination medicines to treat specific types of cancer.

Read More
Our Science|September 8, 2022

Taking the Brakes Off the Immune System: Exploring Immunotherapy Combinations

Our immune system is made up of different types of cells that search for and destroy foreign invaders. These adversaries can include bacteria and viruses, as well as abnormal versions of our own cells, like those in cancerous tumors.

Read More